Global Orexin Receptor Type 2 Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Orexin Receptor Type 2 Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Orexin Receptor Type 2 report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Orexin Receptor Type 2 market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Insomnia and Narcolepsy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Orexin Receptor Type 2 industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Orexin Receptor Type 2 key companies include Actelion Pharmaceuticals Ltd, Eisai Co Ltd, Evotec AG, Heptares Therapeutics Ltd, Idorsia Ltd, Johnson & Johnson, Merck & Co Inc, OptiNose US Inc and Yangtze River Pharmaceutical Group, etc. Actelion Pharmaceuticals Ltd, Eisai Co Ltd, Evotec AG are top 3 players and held % share in total in 2022.
Orexin Receptor Type 2 can be divided into HTL-6641, MK-8133, Lemborexant and OPN-021, etc. HTL-6641 is the mainstream product in the market, accounting for % share globally in 2022.
Orexin Receptor Type 2 is widely used in various fields, such as Insomnia, Narcolepsy, Sleep Disorders and Major Depressive Disorder, etc. Insomnia provides greatest supports to the Orexin Receptor Type 2 industry development. In 2022, global % share of Orexin Receptor Type 2 went into Insomnia filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Orexin Receptor Type 2 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Actelion Pharmaceuticals Ltd
Eisai Co Ltd
Evotec AG
Heptares Therapeutics Ltd
Idorsia Ltd
Johnson & Johnson
Merck & Co Inc
OptiNose US Inc
Yangtze River Pharmaceutical Group
Segment by Type
HTL-6641
MK-8133
Lemborexant
OPN-021
YNT-185
Others
Insomnia
Narcolepsy
Sleep Disorders
Major Depressive Disorder
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Orexin Receptor Type 2 market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Orexin Receptor Type 2 introduction, etc. Orexin Receptor Type 2 Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Orexin Receptor Type 2 market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Orexin Receptor Type 2 industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Orexin Receptor Type 2 key companies include Actelion Pharmaceuticals Ltd, Eisai Co Ltd, Evotec AG, Heptares Therapeutics Ltd, Idorsia Ltd, Johnson & Johnson, Merck & Co Inc, OptiNose US Inc and Yangtze River Pharmaceutical Group, etc. Actelion Pharmaceuticals Ltd, Eisai Co Ltd, Evotec AG are top 3 players and held % share in total in 2022.
Orexin Receptor Type 2 can be divided into HTL-6641, MK-8133, Lemborexant and OPN-021, etc. HTL-6641 is the mainstream product in the market, accounting for % share globally in 2022.
Orexin Receptor Type 2 is widely used in various fields, such as Insomnia, Narcolepsy, Sleep Disorders and Major Depressive Disorder, etc. Insomnia provides greatest supports to the Orexin Receptor Type 2 industry development. In 2022, global % share of Orexin Receptor Type 2 went into Insomnia filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Orexin Receptor Type 2 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Actelion Pharmaceuticals Ltd
Eisai Co Ltd
Evotec AG
Heptares Therapeutics Ltd
Idorsia Ltd
Johnson & Johnson
Merck & Co Inc
OptiNose US Inc
Yangtze River Pharmaceutical Group
Segment by Type
HTL-6641
MK-8133
Lemborexant
OPN-021
YNT-185
Others
Segment by Application
Insomnia
Narcolepsy
Sleep Disorders
Major Depressive Disorder
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Orexin Receptor Type 2 market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Orexin Receptor Type 2 introduction, etc. Orexin Receptor Type 2 Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Orexin Receptor Type 2 market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.